- Home
- PLBY vs CADL Comparison
PLBY vs CADL Comparison
Compare PLBY & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- CADL
- Stock Information
- Founded
- PLBY 1953
- CADL 1999
- Country
- PLBY United States
- CADL United States
- Employees
- PLBY N/A
- CADL N/A
- Industry
- PLBY Recreational Games/Products/Toys
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- CADL Health Care
- Exchange
- PLBY Nasdaq
- CADL Nasdaq
- Market Cap
- PLBY 142.4M
- CADL 159.1M
- IPO Year
- PLBY N/A
- CADL 2021
- Fundamental
- Price
- PLBY $1.88
- CADL $6.60
- Analyst Decision
- PLBY Buy
- CADL Strong Buy
- Analyst Count
- PLBY 2
- CADL 1
- Target Price
- PLBY $2.35
- CADL $11.00
- AVG Volume (30 Days)
- PLBY 742.3K
- CADL 8.6M
- Earning Date
- PLBY 11-12-2024
- CADL 11-14-2024
- Dividend Yield
- PLBY N/A
- CADL N/A
- EPS Growth
- PLBY N/A
- CADL N/A
- EPS
- PLBY N/A
- CADL N/A
- Revenue
- PLBY $124,761,000.00
- CADL N/A
- Revenue This Year
- PLBY N/A
- CADL N/A
- Revenue Next Year
- PLBY N/A
- CADL N/A
- P/E Ratio
- PLBY N/A
- CADL N/A
- Revenue Growth
- PLBY 30.09
- CADL N/A
- 52 Week Low
- PLBY $0.52
- CADL $1.02
- 52 Week High
- PLBY $1.99
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- PLBY 70.93
- CADL 55.49
- Support Level
- PLBY $1.33
- CADL $4.42
- Resistance Level
- PLBY $1.99
- CADL $7.28
- Average True Range (ATR)
- PLBY 0.17
- CADL 1.35
- MACD
- PLBY 0.02
- CADL 0.26
- Stochastic Oscillator
- PLBY 85.64
- CADL 22.48
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.